Cost Analysis With Censored Data

Economic evaluation of medical interventions has become an accepted, and often required, adjunct to the standard effectiveness and safety assessment in clinical research. However, the statistical analysis can be challenging due to censored cost data, as commonly obtained in medical studies. Over the past decade, important statistical issues that arise from censored cost data have been identified and a number of advances made to tackle them. In this article, we will describe these issues, including induced dependent censoring and limited identifiability with the cost distribution, and review recent statistical developments. Available methods address either time-restricted medical cost or lifetime medical cost jointly with survival time. Their applicability and limitation in various practical situations will be discussed

Censoring (clinical trials) · Data science · Econometrics · Economics · Identifiability · Machine learning · Risk analysis (engineering) · Computer Science · Health Systems, Economic Evaluations, Quality of Life · Healthcare cost, quality, practices · Healthcare Policy and Management · Medicine

• Issues for the Next Generation of Health Care Cost Analyses

  Anirban Basu, Willard G Manning•Medical Care•2009

  Incluir item

• Health Care Costing

  Joseph Lipscomb, K Robin Yabroff et al.•Medical Care•2009

  Incluir item

• Advancing the Science of Health Care Costing

  Joseph Lipscomb, Paul G Barnett et al.•Medical Care•2009

  Incluir item

• Inventory of Data Sources for Estimating Health Care Costs in the United States

  Jennifer L Lund, K Robin Yabroff et al.•Medical Care•2009

  Incluir item

• Overview of Methods to Estimate the Medical Costs of Cancer

  William E Barlow•Medical Care•2009

  Incluir item

• A Generalization of Sampling Without Replacement from a Finite Universe

  Daniel G Horvitz, Donovan J Thompson•Journal of the American…•1952

  Incluir item

• Estimation of Regression Coefficients When Some Regressors are not Always Observed

  James M Robins, Andrea Rotnitzky et al.•Journal of the American…•1994

  Incluir item

• The Analysis of Censored Treatment Cost Data in Economic Evaluation

  Paul Fenn, Alistair Mcguire et al.•Medical Care•1995

  Incluir item